Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial

PURPOSE: This trial aims to explore the efficacy and safety of involved-field irradiation (IFI) combined with paclitaxel plus cisplatin as concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma (ESCC), under the premise of intensity-modulated radiotherapy (IMRT). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Fang, Ying, Gu, Dayong, Du, Mingyu, Zhang, Zhi, Sun, Lei, Zhou, Guoren, Ye, Jinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185874/
https://www.ncbi.nlm.nih.gov/pubmed/35681233
http://dx.doi.org/10.1186/s13014-022-02078-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185874/
https://www.ncbi.nlm.nih.gov/pubmed/35681233
http://dx.doi.org/10.1186/s13014-022-02078-3

Ejemplares similares